Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.04 USD | +0.28% | +4.30% | 0.00% |
Mar. 27 | Metagenomi 2023 Loss Widens, Revenue Rises | MT |
Mar. 27 | Metagenomi, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 32.37M | Sales 2025 * | 39.18M | Capitalization | 264M |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -119M | EV / Sales 2024 * | 8.15 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.73 x |
P/E ratio 2024 * |
-2.59
x | P/E ratio 2025 * |
-2.54
x | Employees | 236 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.51% |
1 day | +0.28% | ||
1 week | +4.30% | ||
Current month | +0.28% | ||
1 month | -34.94% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 7.04 | +0.28% | 88,913 |
24-04-30 | 7.02 | -13.33% | 86,790 |
24-04-29 | 8.1 | +7.57% | 125,994 |
24-04-26 | 7.53 | +11.72% | 139,371 |
24-04-25 | 6.74 | -0.15% | 357,204 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 263M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- MGX Stock